Ashwagandha affects at least three systems that overlap with stimulant pharmacology: the hypothalamic-pituitary-adrenal (HPA) axis, thyroid hormone production, and GABAergic neurotransmission
2.3Nonalcoholic fatty liver disease and NRF-2 To define nonalcoholic fatty liver disease, it should be proven, by means of an image or a histological method, that the steatosis is not related to any secondary cause that conditioned the accumulation of liver fat, such as alcohol consumption, infection by hepatitis C virus, or any congenital metabolic disorder, steatogenic medications or among other causes
Saxena AR, Frias JP, Brown LS, et al
Currently, there are five registered clinical trials to evaluate the effect of semaglutide in AUD, and some are already recruiting 28,29,30,31,32
In fact, LC worsened CIPN severity over time